---
schema_version: "secwatch.filing_event.v1"
accession: "0001576885-23-000039"
form_type: "8-K"
ticker: "ABOS"
cik: "0001576885"
company_name: "Acumen Pharmaceuticals, Inc."
filed_at: "2023-06-08T23:59:59+00:00"
generated_at: "2026-06-14T04:55:57.979307+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Acumen shareholders approve officer exculpation amendment; re-elect directors

## Summary
- Shareholders approved certificate amendment to allow officer exculpation per Delaware law (27,061,448 votes for, 99.9% of votes cast).
- Re-elected Dr. Derrell Porter (27,096,949 for) and Dr. Laura Stoppel (24,440,807 for) as Class II directors until 2026.
- Ratified Ernst & Young as independent auditor for FY2023 with 36,099,071 votes for, 185 against, 214 abstained.
- Quorum of 36,099,470 shares (87.99% of 41,025,062 outstanding) present at annual meeting.

## SEC filing metadata
- accession: 0001576885-23-000039
- form_type: 8-K
- ticker: ABOS
- cik: 0001576885
- company_name: Acumen Pharmaceuticals, Inc.
- filed_at: 2023-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576885/000157688523000039/0001576885-23-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576885/000157688523000039/abos-20230606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001576885-23-000039
- JSON: https://secwatch.observer/filing/0001576885-23-000039.json
- Plain text: https://secwatch.observer/filing/0001576885-23-000039.txt

## Key facts
- Governance Changes
  Acumen Pharmaceuticals, Inc.: Amended certificate of incorporation to reflect Delaware law provisions allowing for exculpation of officers (effective 2023-06-06).
  - Change: charter amendment
  - Effective: 2023-06-06
  source text: On June 6, 2023, Acumen Pharmaceuticals, Inc. (the “ Company ”) held its 2023 annual meeting of stockholders (the “ Annual Meeting ”). As described in Item 5.07 below, the Company’s stockholders approved the Company’s Amended and Restated Certificate of Incorporation (the “ Certificate of Incorporation ” and, as amended, the “ Amended Certificate of Incorporation ”) to reflect Delaware law provisions allowing for the exculpation of officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576885/000157688523000039/0001576885-23-000039-index.htm
- Shareholder Votes
  Acumen Pharmaceuticals, Inc. shareholders approved Election of two Class II directors at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal No. 1: The stockholders elected two nominees to serve as Class II directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Derrell Porter, M.D. 27,096,949 5,040 Laura Stoppel, Ph.D. 24,440,807 2,661,182
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576885/000157688523000039/0001576885-23-000039-index.htm
- Shareholder Votes
  Acumen Pharmaceuticals, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal No. 2: The stockholders ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows: Votes For Votes Against Abstained Ratification of appointment of Ernst & Young LLP 36,099,071 185 214
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576885/000157688523000039/0001576885-23-000039-index.htm
- Shareholder Votes
  Acumen Pharmaceuticals, Inc. shareholders approved Approval of amendment to Certificate of Incorporation to reflect Delaware law provisions allowing for exculpation of officers at the 2023-06-06 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal No. 3: The stockholders approved an amendment to the Company’s Certificate of Incorporation to reflect Delaware law provisions allowing for the exculpation of officers. The votes were cast as follows: Votes For Votes Against Abstained Amendment to Certificate of Incorporation 27,061,448 39,649 892
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576885/000157688523000039/0001576885-23-000039-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.